The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy

Annals of Neurology

Volumn 39, Issue 1, 1996, Pages 95-99

  Petroff, Ognen A C ^a   Rothman, Douglas L ^b   Behar, Kevin L ^a   Lamoureux, D ^a   Mattson, Richard H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; PHENYTOIN; PRIMIDONE; VALPROIC ACID;

4 AMINOBUTYRIC ACID BRAIN LEVEL; ADULT; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEX PARTIAL SEIZURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HUMAN; MALE; OCCIPITAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ACETIC ACIDS; ADULT; AMINES; ANTICONVULSANTS; CARBAMAZEPINE; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY, COMPLEX PARTIAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OCCIPITAL LOBE; PROTONS; TREATMENT OUTCOME;

EID: 0030052878     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410390114     Document Type: Article

References (40)

1. Meldrum BS. GABAergic mechanisms in the pathogenesis and treatment of epilepsy- Br J Clin Pharmacol 1989;27(suppl 1):3S-11S
2. Tasker JG, Dudek FE. Electrophysiology of GABA-mediated synaptic transmission and possible roles in epilepsy. Neurochem Res 1991;10:251-262
3. During MJ, Ryder KM, Spencer DD. Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature 1995;376:174-177
4. Wood JH, Hare TA, Glaeser BS, et al. Low cerebrospinal fluid γ-aminobutyric acid content in seizure patients. Neurology 1979;29:1203-1208
5. Löscher W, Schmidt D. Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res 1994;17:95-134
6. Ramsay RE. Clinical efficacy and safety of gabapentin. Neurology 1994;44(suppl 5):S23-S30
7. Chadwick D. Gabapentin. clinical use. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepilepric drugs. 4th ed New York: Raven, 1995:851-856
8. Taylor CP. Emerging perspectives on the mechanism of action of gabapentin. Neurology 1994;44(suppl 5):S10-S16
9. Gotz E, Feuerstein TJ, Lais A, Meyer DK. Effects of gabapen-tin on release of gamma-aminobutyric acid from slices of rat neostriatum. Arzneimittelforschung 1993;43:636-638
10. Kocsis JD, Honmou O. Gabapentin increases GABA-induced depolarization in rat neonatal optic nerve. Neurosci Lett 1994;169:181-184
11. Honmou O, Kocsis JD, Richerson GB. Gabapentin potentiates the conductance increase induced by nipecotic acid in CA1 pyramidal neurons in vitro Epilepsy Res 1995;20:193-202
12. During MJ, Spencer DD. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 1993;341:1607-1613
13. During MJ. Dynamic neurochemical alterations in human temporal lobe epilepsy. Clin Neurosci 1994;2:53-63
14. 1H-double resonance difference spectroscopy of the rat brain in vivo. Proc Natl Acad Sci USA 1984;81:6330-6334
15. 1H NMR measurements of GABA levels in human brain in vivo. Proc Natl Acad Sci USA 1993;90:5662-5666
16. 31P NMR spectroscopic study of rat brain in vivo. Magn Reson Med 1994;31:660-667
17. 1H spectroscopic measurements of GABA, glutamate, and glutamine in human brain Epilepsia 1995;36:457-464
18. Mattson RH, Petroff O, Rothman D, Behar K. Vigabatrin: effects on human brain GABA levels by nuclear magnetic resonance spectroscopy. Epilepsia 1994;53(suppl 5):S29-S32
19. Mattson RH, Cramer JA, Collins JF, Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med 1992;327:765-771
20. 1H NMR spectra of human brain. Magn Reson Med 1994;32:294-302
21. Harding VJ, Eagles BA. The creatine content of brain. J Biol Chem 1924;60:301-310
22. Petroff OAC, Spencer D, Alger JR, Prichard JW. High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology 1989;39:1197-1202
23. Gardner MJ, Altman DG. Statistics with confidence. London: British Medical Journal, 1989
24. Loscher W, Hoenack D, Taylor CP. Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain. Neurosci Lett 1991;128:150-154
25. Taylor CP, Vartanian MG, Andruszkiewicz R, Silverman RB. 3-Alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents. Epilepsy Res 1992;11:103-110
26. Taylor CP. Gabapentin: mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. 4th ed. New York: Raven, 1995:829-841
27. Vollmer KO, von Hodenberg A, Kolle EU. Pharmacokinetics and metabolism of gabapentin in rat, dog, and man. Arzneimittelforschung 1986;36:830-839
28. Ojemann LM, Friel PN, Ojemann GA. Gabapentin concentrations in human brain. Epilepsia 1988;29:694
29. McLean MJ. Clinical pharmacokinetics of gabapentin. Neurology 1994;44(suppl 5):S17-S22
30. Bernasconi R, Bittiger H, Schmutz M, et al. Is the estimation of the GABA turnover rate in vivo a tool to differentiate between various types of drugs interfering with the GABA-benzodiazepine-ionophore receptor complex? Neuropharmacology 1984;23:815-816
31. Martin DL. Regulatory properties of brain glutamate decarboxylase. Cell Mol Neurobiol 1987;7:237-253
32. Martin DL, Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J Neurochem 1993;60:395-407
33. Erlander MG, Tillakaratne NJK, Feldblum S, et al. Two genes encode distinct glutamate decarboxylases. Neuron 1991;7:91 -100
34. Erlander MG, Tobin AJ. The structural and functional heterogeneity of glutamic acid decarboxylase: a review. Neurochem Res 1991;16:215-226
35. Miller LP, Walters JR. Effects of depolarization on cofactor regulation of glutamic acid decarboxylase in substantia nigra synaptosomes. J Neurochem 1979;33:533-539
36. 13C decoupled spectroscopic measurements of lactate and gluta-mate in the rat btain in vivo. Proc Natl Acad Sci USA 1985;82:1633-1637
37. Mason GF, Rothman DL, Behar KL, Shulman RG. NMR determination of the TCA cycle rate and alpha-ketoglutarate/glutamate exchange rate in rat brain. J Cereb Blood Flow Metab 1992;12:434-447
38. 13C glucose. J Neurochem 1994;63:1377-1385
39. Mason GF, Gruetter R, Rothman DL, et al. Simultaneous determination of the rates of the TCA cycle, glucose utilization, alpha-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J Cereb Blood Flow Metab 1995;18:12-25
40. Manor D, Rothman D, Hyder F, et al. Turnover of cortical GABA and glutamate from 1-13C-glucose in rats treated with the GABA-transaminase inhibitor vigabatrin. In: Proceedings of the Society of Magnetic Resonance. Berkeley: Society of Magnetic Resonance, 1995:270